---
title: "Quoin Pharmaceuticals, Ltd. (QNRX.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/QNRX.US.md"
symbol: "QNRX.US"
name: "Quoin Pharmaceuticals, Ltd."
industry: "生物技術"
---

# Quoin Pharmaceuticals, Ltd. (QNRX.US)

| Item | Detail |
|------|--------|
| Industry | 生物技術 |
| Location | 美股市場 |
| Website | [quoinpharma.com](https://quoinpharma.com) |

## Company Profile

Quoin Pharmaceuticals, Ltd.是一家處于后期階段的專業制藥公司，專注于在美國開發和商業化針對罕見病和孤兒病的治療產品。該公司的主要產品是 QRX003，一種用于治療內特頓綜合症（Netherton Syndrome, NS）的外用乳液。它還在開發 QRX004 用于治療隱性營養不良性大皰性表皮松解症；QRX007 用于治療內特頓綜合症；以及 QRX008 用于治療硬皮病。公司與昆士蘭科技大學簽訂了研究協議；與 Skinvisible Inc.簽訂了許可協議；與 Axella Research LLC 簽訂了咨詢協議；並與 Therapeutics Inc.簽訂了主服務協...

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -1.05 | 201/605 | - | - | - |
| PB | -11.92 | 538/605 | 1.72 | 0.90 | 0.66 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2025-11-20T05:00:00.000Z

Total Analysts: **3**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 1 | 33% |
| Overweight | 1 | 33% |
| Hold | 0 | 0% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 8.96 |
| Highest Target | 70.00 |
| Lowest Target | 25.00 |

## References

- [Company Overview](https://longbridge.com/en/quote/QNRX.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/QNRX.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/QNRX.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.